MedTrace Logo

Further Acute Research of a Subcutaneous Implantable Defibrillator (S-ICD) System

NCT00399217 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 55

Last updated 2017-02-16

No results posted yet for this study

Summary

The purpose is to further evaluate the operation, safety, and feasibility of a subcutaneous implantable defibrillator (S-ICD) system in patients who require an implantable cardioverter defibrillator (ICD)for treating ventricular tachyarrhythmias. The S-ICD electrode and pulse generator emulator will be briefly implanted and tested during the standard implantation procedure of an ICD, but then the S-ICD system will be removed entirely.

Conditions

  • Ventricular Fibrillation
  • Ventricular Tachycardia

Interventions

DEVICE

Subcutaneous Implantable Defibrillator (S-ICD) system

DEVICE

ICD

Sponsors & Collaborators

  • Boston Scientific Corporation

    lead INDUSTRY

Principal Investigators

  • Andrew A Grace, MD, PhD · Papworth Hospital NHS Foundation Trust

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-11-30
Primary Completion
2008-06-30
Completion
2008-06-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00399217 on ClinicalTrials.gov